Marybeth Dixon, MD
Obstetrics & Gynecology · Norfolk, VANPI 1992812903
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.5% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $17.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$303
- Bayer$179
- Sumitomo Pharma America, Inc.$178
- Pfizer$140
- Astellas Pharma US Inc$134
- Daiichi Sankyo Inc.$124
- plus $749 from 23 others
What the payments were for
- Food & beverage$1,78198%
- Education$272%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 17 | $303 |
| Bayer | 10 | $179 |
| Sumitomo Pharma America, Inc. | 9 | $178 |
| Pfizer | 10 | $140 |
| Astellas Pharma US Inc | 7 | $134 |
| Daiichi Sankyo Inc. | 6 | $124 |
| Myovant Sciences Inc. | 4 | $77 |
| Hologic Sales And Service, LLC | 4 | $74 |
| Organon | 4 | $73 |
| Exeltis, USA Inc. | 3 | $55 |
| Coopersurgical, Inc. | 3 | $48 |
| Millicent US Inc | 3 | $45 |
| Merck | 3 | $42 |
| Agile Therapeutics, Inc. | 2 | $37 |
| Mayne Pharma Commercial LLC | 2 | $35 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Novartis | 1 | $30 |
| AMAG Pharmaceuticals, Inc. | 2 | $27 |
| Aspira Women's Health Inc | 2 | $26 |
| Therapeuticsmd, Inc. | 1 | $24 |
| Evofem Biosciences, Inc. | 1 | $20 |
| Scynexis, Inc. | 1 | $19 |
| Minerva Surgical, Inc | 1 | $13 |
| Lupin Inc. | 1 | $13 |
| Avion Pharmaceuticals | 1 | $13 |
| Olympus America Inc. | 1 | $12 |
| Mycovia Pharmaceuticals, Inc. | 1 | $12 |
| Meditrina | 1 | $12 |
| Smith+Nephew | 1 | $11 |
How this compares
$1,808 in reported general payments places this provider in the 75th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 45 | $2,959 |
| Medroxyprogesterone Acetate | 11 | $75 |
| Fluconazole | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Norfolk
- Thomas KimbleNorfolk$286K
- Krystle LappinenNorfolk$20K
- Joseph HudgensNorfolk$18K
- Peter TakacsNorfolk$8K
- Jack AyoubLeesburg$279K
- Kurian ThottStafford$216K
- Nina SmithHarrisonburg$199K
- Joseph TroiseSalem$144K
- Bunan AlnaifChesapeake$139K
- James JonesRichmond$134K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.